Event Categories: Healixia

Lou Guffroy will present and discuss the current literature, the development of a prospective questionnaire on eConsent experiences sent to +3000 clinical research experts in Belgium, The Netherlands and Luxembourg. The results and recommendations of the survey, addressed to 5 different stakeholders, next to expert interviews, will conclude this presentation.

Since the start of the COVID-19 outbreak clinical research has been impacted around the globe. Apart from the difficulties, the epidemic has also been a catalyst for positive change enabling faster uptake of new processes and technologies. This webinar aims to provide you with a unique perspective, bringing together first hand experiences from site and sponsor about opportunities and challenges.

Patient preferences and engagement in drug development and evaluation: value, methods & challenges & Incorporating the patient voice along the medicines’ lifecycle.

The world has woken up to understand the disturbing impact of a global virus epidemic. Scientists have however been studying the risks for many years, trying to find novel ways to model and predict the spread of viruses.

An introduction to the current regulatory framework for advanced therapies, including the legislation on ATMPs, Tissues and Cells and some ethics specifics to consider in a do's and don'ts to reach an effective shortening of pharmaceutical development time.